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Airways resistance and lung volume before and after 
bronchodilator therapy in symptomatic preterm infants 
B. YUKSEL AND A. GREENOUGH* 
Department of Child Health, King’s College Hospital, London SE5 9RS, U.K. 
Preterm infants who are symptomatic at follow-up frequently have a high airways resistance (RAW) and a low 
functional residual capacity to thoracic gas volume ratio (FRC:TGV). The aim of this study was to assess the 
effect of bronchodilator therapy on these lung function abnormalities. Thirty-four infants who had recurrent 
respiratory symptoms and a median gestational age 28 weeks, were studied at a median postnatal age of 10 
months (range 6-20). TGV and RAW were measured using a plethysmographic technique and FRC by helium 
gas dilution. Specific conductance (SGAW) was calculated from TGV and RAW. All measurements were made 
immediately before and 15 min after nebulized salbutamol. Administration of nebulized salbutamol was 
associated with a reduction of RAW (P<O.OOl) and an increase in SGAW (P<O.OOl), FRC (P<O.OOl). These 
effects on lung function were independent of postnatal age. 
Introduction 
Infants born preterm frequently have recurrent 
respiratory symptoms at follow-up (1,2). This respi- 
ratory morbidity is associated with lung function 
abnormalities which include a high airways resistance 
(RAW), (3,4), a reduced functional residual capacity 
(FRC) and a low functional residual capacity to 
thoracic gas volume (FRC:TGV) ratio (5). The aim 
of this study was to assess the effect of bronchodila- 
tor therapy on these lung function abnormalities. As 
there remains controversy regarding the response of 
very young children to bronchodilator (6,7), we also 
wished to determine if any effect on the lung function 
abnormalities we demonstrated was related to post- 
natal age. 
Materials and Methods 
STUDY DESIGN 
All inborn preterm infants of birthweight less than 
2000 g discharged from the neonatal intensive care 
unit (NICU) have lung function measurements per- 
formed at approximately 6-monthly intervals during 
the first 2 years of life. Thirty-four of these infants 
who were symptomatic and had respiratory function 
measurements consecutively performed in the Paedi- 
atric Respiratory Laboratory were recruited into the 
study. 
Received 19 June 1992 and accepted in revised form 31 December 
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*Author to whom correspondence should be addressed. 
The infants were examined after a medical history 
was taken, weight and height measured. Oral chloral 
hydrate (SO-100 mg kg-‘) was used for sedation. 
Lung mechanics (TGV, RAW and FRC) were 
measured during quiet sleep with the infants in the 
supine position and the FRC:TGV ratio calculated. 
Quiet sleep was diagnosed by lack of eye or body 
movements and regular breathing. Nasal resistance 
was not measured. The measurements were repeated 
15 min after nebulized bronchodilator therapy. The 
bronchodilator used was salbutamol, administered as 
iso-osmolar nebules (2.5 mg salbutamol in 2.5 of 
0.9% saline) via a mini-Neb nebulizer (Bard Ltd) and 
face mask using an Inspiron compressor (Bard Ltd) 
with a flow of 8 1 min-’ for 4 min. The pH of the 
nebules is 4 and they do not contain preservatives. 
PULMONARY E-UNCTION TESTS 
TGV and RAW were measured using a whole body 
plethysmograph (Hammersmith Hospital Infant 
Whole Body Plethysmograph, Department of 
Medical Engineering, Hammersmith Hospital). The 
plethysmograph has a total volume of 90 1. The 
infant breathed through a face mask, which was 
connected to the rebreathing bag via a heated pneu- 
motachograph. The face mask was sealed around the 
infant’s nose and mouth using silicone putty to 
ensure an airtight seal. The infant breathed through 
a heated, humidified rebreathing system to avoid 
box pressure changes due to the heating and cooling 
of respired gas. TGV was measured at the end of 
a normal inspiration and RAW at two-thirds of 
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maximum inspiratory flow by the classical techniques 
of DuBois et al. suitably modified for infants (8,9). 
The signals were recorded on ultraviolet recording 
paper for later analysis. The traces were coded and 
analysis performed by a researcher unaware of the 
infant’s clinical details. TGV was calculated from five 
breaths during an occlusion and at least five separate 
occlusions were made and the results meaned. Tidal 
volume was subtracted to get to the final TGV result. 
RAW was calculated from at least ten breaths. The 
measurements were corrected for the apparatus dead 
space including the face mask (15 ml) and resistance 
(8 cmH,O 1-l s-l, measured at flows of between 5 
and 15 1 min- ‘). Specific conductance (SGAW) was 
then calculated. 
The plethysmograph was calibrated dynamically 
before and after each measurement at a series of 
frequencies ranging from 20 to 120 per min, this 
range encompassed the breathing rate of all infants 
studied before and after bronchodilator. The differ- 
ence in the calibration values at these different 
frequencies was less than 2%. 
After completion of the measurements of TGV and 
RAW the infant’s face mask was connected to a 
spirometer (Gould Pulmonet III) for the measure- 
ment of FRC by a helium gas dilution technique. The 
spirometer has an internal carbon dioxide absorber 
and an adjustable oxygen supply and has a total 
volume of 6 1. The water-sealed spirometer incorpo- 
rates a digital display of FRC which was recorded on 
the trace at 15-s intervals. Equilibration was assumed 
to have occurred when there had been no change in 
the FRC readout over a 30-s period. All the FRC 
traces were coded and then analysed without knowl- 
edge of the clinical details. From the trace, the 
equilibration point and end expiratory level were 
determined and FRC thus calculated. The results 
were then converted to body temperature pressure 
saturated conditions. The accuracy of the spir- 
ometer was checked daily with a calibrated syringe 
(Vitalograph, Buckingham, U.K.). 
The repeatability of TGV, RAW and SGAW was 
calculated according to the method of Bland and 
Altman (10). From each patient, the maximum and 
minimum baseline results of TGV, RAW and SGAW 
were selected. The difference between these was cal- 
culated for each subject, the sum of these differences 
squared was then divided by the number of subjects, 
the square root of this result gave the standard 
deviation (SD) of the difference. The coefficient of 
repeatability was calculated as twice the SD and this 
was18mlforTGV,5~5cmH,01-1s-‘forRAwand 
0.0141 cmH,O-’ s-’ for SGAW. The coefficient of 
repeatability after administration of bronchodilator 
was 16 ml for TGV and 4.8 cmH,O l- ’ s- ’ for RAW. 
To assess the reproducibility of the measurement of 
FRC, two separate measurements were made in 20 
children of similar gestational and postnatal age to 
the study population. The coefficient of repeatability 
was calculated from these results as described above, 
and was 15 ml or 2.3 ml kg-i. 
STATISTICAL ANALYSIS 
Differences in lung function before and after the 
bronchodilator administration were assessed for sta- 
tistical significance by using the paired Wilcoxon 
rank sum test. To assess if associations were signifi- 
cant a Spearman’s rank correlation coefficient was 
calculated. The significance level was taken at 
PCO.05. 
STUDY POPULATION 
The 34 infants (Table 1) had a median gestational 
age of 28 weeks (range 2434) and birthweight of 
1179 g (range 6561930). They were studied at a 
median postnatal age of 10 months (range 620). All 
the infants had suffered from respiratory distress 
syndrome (RDS) in the neonatal period but six had 
had only mild disease requiring oxygen for less than 
2 h and no assisted ventilation. The median duration 
of ventilation (IPPV) of the 34 infants was 1 day 
(range @49) and duration of oxygen dependency 
was 4 days (range 0.1-340). Seven infants were still 
oxygen-dependent at 28 days but only one infant 
suffered from bronchopulmonary dysplasia. No 
infant was receiving diuretics or was oxygen depen- 
dent at the time of the study. All of the infants had 
recurrent respiratory symptoms; defined as the occur- 
rence of wheeze and/or cough on at least 4 days per 
week over the 4 weeks prior to testing and wheezed 
for at least 3 days following all respiratory infections. 
This frequency of symptoms was obtained from 
parental history and confirmed by examination of the 
diary cards kept by the parents of all infants recruited 
into the study. None of the infant had had symptoms 
for 24 h prior to testing. 
The protocol was approved by the King’s College 
Hospital Ethics Committee and parents gave 
informed consent prior to entry into the study. 
Results 
Administration of bronchodilator was associ- 
ated with a significant reduction in RAW from a 
median of 40 cmH,O l- ’ s-l (range 22-100) to 
32 cmH,O 1-i s-l (range 19-63) P<O.OOl (Table 1). 
SGAW significantly increased from a median of 
0.110 1 s-l cmH,O-’ (range 0.036-0.239) to 
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Fig. 1 Change in the FRC:TGV ratio in response to 
bronchodilator. Individual data is demonstrated by linked 
data points. 
0.135 1 s- ’ cmH,O- ’ (range 0.061LO.294) (BO.001). 
FRC increased from a median of 28 ml kg- ’ (range 
1842) to 32 ml kg-’ (range 20-42), (P<O.OOl) and 
TGV decreased from a median of 36.5 ml kg- ’ 
(range 2348) to 35.5 ml kg- ’ (range 24-46), but this 
was not statistically significant. The FRC:TGV ratio 
increased after the bronchodilator; from a median of 
0.82 (range 0.524.96) to 0.93 (range 0.60-0.99), 
(P<O.OOl), (Fig. 1). There was no statistically signifi- 
cant change in the breathing pattern following the 
bronchodilator. No significant correlation was found 
between the change in FRC:TGV ratio and RAW in 
response to bronchodilator administration. 
Discussion 
We have demonstrated that amongst these symp- 
tomatic preterm infants bronchodilator therapy 
resulted in significant changes in RAW, SGAW and 
FRC but not TGV. Our airways resistance results are 
high compared to a published reference range (11) 
and results from non-ventilated infants reported by 
Stocks & Godfrey (12), but similar to those docu- 
mented in their ventilated patients (12). The tech- 
nique of measurement used in the present study and 
its reproducibility was very similar to that used 
previously (12). We feel the difference in results may 
be explained by the immaturity of the patients we 
examined. The significant change in SGAW we docu- 
mented in response to the bronchodilator may indi- 
cate a change in both upper and lower airways 
resistance. 
It has been suggested that plethysmographic 
measurement of TGV may be inaccurate in patients 
with evidence of airway obstruction (13,14). Stanescu 
(13) reported that TGV is overestimated in such 
patients, and the degree of error is dependent on the 
distensibility of the extrathoracic airways and sever- 
ity of the airways obstruction. In contrast, Godfrey 
(14) reported that TGV may underestimate lung 
volume in infants with bronchiolitis. We took all 
possible precautions to avoid errors in the measure- 
ment of TGV. All our patients were measured in the 
same posture (15) before and after bronchodilator 
therapy and all were in quiet sleep (16), following 
sedation with chloral hydrate. We also made our 
occlusions at end inspiration, as this minimizes the 
errors due to small airway closure at low lung 
volumes which can occur if occlusions are made at 
end expiration (17). Our TGV results are similar to 
those quoted in the literature both for infants born at 
term (18) or prematurely (12,19). That comparison 
and the lack of significant change in TGV following 
the bronchodilator would suggest our infants were 
not hyperinflated. 
Prior to the administration of bronchodilator 
therapy we found the FRC:TGV ratio to be lower 
than 0.9 in the majority of our patients, this differ- 
ence was due to a low FRC. To measure FRC we 
used a spirometer with a volume of 6 1, this equip- 
ment has been previously used in small babies with 
reliable results (20-22). Our FRC results are within 
the range previously quoted for results obtained by 
dilution methods, that is 21.5 to 37 ml kg- ’ (23). The 
difference between lung volume measured by plethys- 
mography (TGV) and by helium gas dilution (FRC) 
may be explained by areas of the lung which receive 
so little ventilation as to be effectively excluded from 
helium mixing. Prolonging the duration of the FRC 
measurement would allow more time for the helium 
to equilibrate and this might reduce the discrepancy 
between the TGV and FRC. We only assumed equili- 
bration, however, when there had been no change in 
helium concentration for a 30-s period. Thus it seems 
likely that certain areas of the lung must have been 
very inaccessible to the helium allowing extremely 
slow or even no mixing. Once the bronchodilator 
was given, FRC increased, suggesting improved 
accessibility to those areas of lung. 
The difference between the TGV and FRC may 
indicate the presence of trapped gas. Other workers 
(24-26) have used this definition or instead the dif- 
ference in total lung capacity and FRC (27,28) to 
indicate trapped gas. Desmond et al. (25) suggested 
that a discrepancy between the FRC and TGV of 
10% or more indicated significant gas trapping, this 
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was found in the majority of infants included in our 
FRC:TGV ratio (Table l), b;t this would not have 
study. Gas trapping has been previously suggested to 
be a consequence of airway collapse during expira- 
been expected as measurement of RAW assesses 
tion (29) or of bronchoconstriction (30). The former 
mechanism cannot be the explanation in the present 
medium and large airways and the FRC:TGV ratio 
study as, during helium FRC equilibration, the lung 
volume varies from end inspiration to end expiration 
and hence gas trapping was still present at end 
inspiration. It seems more likely that bronchocon- 
striction is the mechanism. Certainly in our infants 
we have evidence of bronchoconstriction as, follow- 
ing therapy, airway resistance decreased and specific 
conductance increased, indicating bronchodilation 
had taken place. We did not, however, find a rela- 
tionshin between the change in RAW and the 
9. DuBois AB, Bodelho SY, Comroe JH. A new method 
for measuring airway resistance in man using a body 
plethysmograph: values in normal subjects and in 
patients with respiratory disease. J Clin Invest 1956; 35: 
321-335. 
10. Bland M, Altman D. Statistical methods for assessing 
agreement between two methods of clinical measure- 
ment. Lancet 1986; i: 307-310. 
11. Radford M. Measurement of airways resistance and 
thoracic gas volume in infancy. Arch Dis Child 1974; 49: 
611-615. 
14. Godfrey S, Beardsmore CS, Maayan C, Bar-Yishay E. 
Can thoracic gas volume be measured in infants with 
airways obstruction? Am Rev Respir Dis 1986; 133: 
245-25 1. 
12. Stocks J, Godfrey S. The role of artificial ventilation, 
oxygen and CPAP in the pathogenesis of lung damage 
in neonates: assessment by serial measurements of lung 
function. Pediatrics 1976; 57: 352-362. 
13. Stanescu DC, Rodenstein D, Canberghs M, Van de 
Woestinjne KP. Failure of body plethysmography in 
bronchial asthma. J Appl Physiol 1982; 52: 939-948. 
small airways. 15. Burki NK. The effects of changes in functional residual 
Several studies have demonstrated that preterm capacity with posture on mouth occlusion pressure and 
infants may benefit from bronchodilator treatment 
even in the first few months of life (31,32). We 
conclude that inhaled bronchodilator therapy results 
16. 
in significant effects on airways resistance and lung 
volume amongst symptomatic infants born preterm. 17. 
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